April JDD Issue Highlights
Here are the issue highlights and Editor Picks for the April issue of JDD:
Dermatologists respond regarding the impact of COVID-19 and examine the potential impact of drugs on susceptibility and severity of infection in Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?
Treatment of Plaque Psoriasis With an Excimer Laser Utilizing a …
Here are the issue highlights and Editor Picks for the April issue of JDD:
Dermatologists respond regarding the impact of COVID-19 and examine the potential impact of drugs on susceptibility and severity of infection in Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?
Treatment of Plaque Psoriasis With an Excimer Laser Utilizing a … 
EPI Health has graciously supported the COVID-19 News and Resource Center.
FREE WEBINAR: COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
Next Steps and JDD invites you to attend this webinar panel to provide discussion, guidance, and leadership for dermatologists and dermatology practices during the global coronavirus pandemic, COVID-19.
Over the course of the 2 hours, 8 differe … 
In this case series, JDD authors evaluate the efficacy and safety of intralesional triamcinolone acetonide injections (ILK) when used with topical minoxidil in the management of traction alopecia in 6 African American women.
Background
Traction alopecia (TA) is a form of hair loss secondary to repetitive and/or prolonged tension to a hair follicle over an extended period of time. This typically … 
In part 1 of this 2-part series, Dr. Kircik along with JDD authors Vlatka Agnetta MD, Abel Torres MD JD MBA, Seemal R. Desai MD, and Adelaide A. Hebert MD, reviewed the regulatory landscape of compounding in dermatology, including federal and state regulations. In part 2, they discuss FDA and USP Compounding Lists/ Categories and provide their final thoughts on in-office compounding.
FDA Compound … 
Medication compounding is defined as any alteration, mixing, or combining of two or more ingredients that make the drug more specific to the needs of the patient.1 Compounded medications are used widely in patient care to meet their individual medical needs and maximize treatment outcomes. The Food and Drug Administration (FDA) and the United States Pharmacopeia (USP) have been the leading organiz … 